Cancer

News

GSK bolts-on immuno-oncology candidate with €3.7bn Merck dea...

GlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an immuno-oncology drug that made a splash at last year’s ESMO meeting.

Views & Analysis

Oncology round-up: CAR-T conference raises hopes for solid t...

Kisaco Research’s CAR-T Congress EU could not have come at a better time – the day after it finished NICE announced it had granted funding for a new use for Novartis’ cancer cell therapy Ky

News

Doctors and patient groups struggle with CAR-T 'hype'

Managing patients’ expectations of CAR-T therapies is proving to be a huge challenge from when selection decisions are made, through the treatment process and when they are recovering at ho

News

CAR-T firms push to improve manufacturing efficiency

Experience with the approved CAR-T drugs from Novartis and Gilead has shown that being able to manufacture enough products fast enough is a major issue when it comes to marketing these cutt

News

T-cells attacking cancer cell illustration of microscopic photos

Hope for CAR-T combination that could tackle solid tumours

Getting CAR-T cells to work in solid tumours is proving a tough nut to crack – and a conference heard details of a cutting-edge approach that could inform clinical trials in the future.

News

No new patients should take Lilly's cancer drug Lartruvo, sa...

Regulators on both sides of the Atlantic have ruled that no new patients should start treatment with Eli Lilly’s Lartruvo (olaratumab) for soft tissue sarcoma, after a study that was suppos

GSK bolts-on immuno-oncology candidate with €3.7bn Merck dea...

Oncology round-up: CAR-T conference raises hopes for solid t...

Doctors and patient groups struggle with CAR-T 'hype'

CAR-T firms push to improve manufacturing efficiency

Hope for CAR-T combination that could tackle solid tumours

No new patients should take Lilly's cancer drug Lartruvo, sa...

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks